Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)

NCT01997229 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Refractory Generalized Myasthenia Gravis

Interventions

BIOLOGICAL: Eculizumab
DRUG: Placebo

Sponsor

Alexion Pharmaceuticals, Inc.